Position
Squarepoint Ops LLC in Crispr Therapeutics Ag
Back to the book · All holders of CRSP
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$747.9K$52.44 → $47.57
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 581.1K | $30.5M | — | — | — | 0.0% |
| Q1 2026 | 153.6K | $7.31M | $47.57 | −$747.9K | −$22.4M | 0.0% |